Nov 14, 2025 07:00AM
Aug 13, 2025 12:59PM
Jun 2, 2025 08:10AM
Jun 2, 2025 08:10AM
Apr 23, 2025 10:12AM
Apr 1, 2025 08:01AM
Mar 3, 2025 07:01AM Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
Jan 10, 2025 06:02AM
Feb 28, 2024 07:00AM
Nov 7, 2023 07:00AM
Oct 31, 2023 08:01AM
Oct 31, 2023 08:00AM
Jun 16, 2023 07:36AM
Jun 15, 2023 07:31AM Mersana Therapeutics (MRSN) Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
Jun 15, 2023 07:30AM
May 9, 2023 07:00AM
Mar 13, 2023 07:30AM
Mar 13, 2023 07:30AM
Feb 28, 2023 07:00AM
Jan 25, 2023 08:00AM
Jan 6, 2023 07:01AM Mersana Therapeutics (MRSN) Provides Business Update
Jan 6, 2023 07:00AM
Nov 7, 2022 07:00AM
Sep 12, 2022 08:01AM
Sep 12, 2022 08:00AM
Aug 9, 2022 08:50AM
Aug 8, 2022 04:04PM
Aug 8, 2022 04:02PM Mersana Therapeutics (MRSN) Announces Option Agreement with GSK for the Co-Development and Commercialization of XMT-2056
Aug 8, 2022 04:02PM
May 19, 2022 07:00AM
May 19, 2022 07:00AM
Mar 15, 2022 08:00AM
Feb 28, 2022 06:00AM
Jan 7, 2022 08:00AM
Nov 9, 2021 06:00AM Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
Feb 26, 2021 06:00AM
Jan 19, 2021 08:00AM
Jan 5, 2021 12:49PM
Jan 5, 2021 10:00AM
Nov 9, 2020 06:00AM
Sep 17, 2020 06:06AM
Sep 17, 2020 06:00AM Mersana Therapeutics Reports Updated Interim Data from the Ovarian Cancer Cohort of the XMT-1536 Phase 1 Expansion Study
Aug 11, 2020 08:05AM
Aug 11, 2020 08:00AM
May 27, 2020 08:44AM
May 8, 2020 06:00AM
Nov 6, 2019 06:00AM
Aug 8, 2019 06:00AM
May 9, 2019 06:00AM Mersana Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Updates
May 9, 2019 06:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All